View in EDS HTML Full Text PDF Full Text

Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.

Saved in:
Bibliographic Details
Title: Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
Authors: Akuta N; Toranomon Hospital, Tokyo, Japan. norioakuta@toranomon.gr.jp., Toyota J; Sapporo-Kosei General Hospital, Sapporo, Japan., Karino Y; Sapporo-Kosei General Hospital, Sapporo, Japan., Ikeda F; Okayama University, Okayama, Japan., Ido A; Kagoshima University, Kagoshima, Japan., Tanaka K; Yokohama City University Medical Center, Yokohama, Japan., Takaguchi K; Kagawa Prefectural Central Hospital, Takamatsu, Japan., Naganuma A; Takasaki General Medical Center, Takasaki, Japan., Tomita E; Gifu Municipal Hospital, Gifu, Japan., Chayama K; Hiroshima University, Hiroshima, Japan., Fujiyama S; Kumamoto Shinto General Hospital, Kumamoto, Japan., Inada Y; Miyazaki Medical Center Hospital, Miyazaki, Japan., Yoshiji H; Nara Medical University, Kashihara, Japan., Watanabe H; Bristol-Myers Squibb K.K., Tokyo, Japan., Ishikawa H; Bristol-Myers Squibb K.K., Tokyo, Japan., McPhee F; Bristol-Myers Squibb, Wallingford, CT, USA., Noviello S; Bristol-Myers Squibb, Princeton, NJ, USA., Kumada H; Toranomon Hospital, Tokyo, Japan.
Source: Journal of gastroenterology [J Gastroenterol] 2018 Sep; Vol. 53 (9), pp. 1089-1097. Date of Electronic Publication: 2018 Mar 02.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29500489
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Akuta+N%22">Akuta N</searchLink>; Toranomon Hospital, Tokyo, Japan. norioakuta@toranomon.gr.jp.<br /><searchLink fieldCode="AU" term="%22Toyota+J%22">Toyota J</searchLink>; Sapporo-Kosei General Hospital, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Karino+Y%22">Karino Y</searchLink>; Sapporo-Kosei General Hospital, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Ikeda+F%22">Ikeda F</searchLink>; Okayama University, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Ido+A%22">Ido A</searchLink>; Kagoshima University, Kagoshima, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+K%22">Tanaka K</searchLink>; Yokohama City University Medical Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Takaguchi+K%22">Takaguchi K</searchLink>; Kagawa Prefectural Central Hospital, Takamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Naganuma+A%22">Naganuma A</searchLink>; Takasaki General Medical Center, Takasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Tomita+E%22">Tomita E</searchLink>; Gifu Municipal Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Chayama+K%22">Chayama K</searchLink>; Hiroshima University, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Fujiyama+S%22">Fujiyama S</searchLink>; Kumamoto Shinto General Hospital, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Inada+Y%22">Inada Y</searchLink>; Miyazaki Medical Center Hospital, Miyazaki, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshiji+H%22">Yoshiji H</searchLink>; Nara Medical University, Kashihara, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+H%22">Watanabe H</searchLink>; Bristol-Myers Squibb K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ishikawa+H%22">Ishikawa H</searchLink>; Bristol-Myers Squibb K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22McPhee+F%22">McPhee F</searchLink>; Bristol-Myers Squibb, Wallingford, CT, USA.<br /><searchLink fieldCode="AU" term="%22Noviello+S%22">Noviello S</searchLink>; Bristol-Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Kumada+H%22">Kumada H</searchLink>; Toranomon Hospital, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229430794%22">Journal of gastroenterology</searchLink> [J Gastroenterol] 2018 Sep; Vol. 53 (9), pp. 1089-1097. <i>Date of Electronic Publication: </i>2018 Mar 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9430794 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1435-5922 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209441174%22">09441174 </searchLink><i>NLM ISO Abbreviation: </i>J Gastroenterol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29500489
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00535-018-1445-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1089
    Titles:
      – TitleFull: Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Akuta N
      – PersonEntity:
          Name:
            NameFull: Toyota J
      – PersonEntity:
          Name:
            NameFull: Karino Y
      – PersonEntity:
          Name:
            NameFull: Ikeda F
      – PersonEntity:
          Name:
            NameFull: Ido A
      – PersonEntity:
          Name:
            NameFull: Tanaka K
      – PersonEntity:
          Name:
            NameFull: Takaguchi K
      – PersonEntity:
          Name:
            NameFull: Naganuma A
      – PersonEntity:
          Name:
            NameFull: Tomita E
      – PersonEntity:
          Name:
            NameFull: Chayama K
      – PersonEntity:
          Name:
            NameFull: Fujiyama S
      – PersonEntity:
          Name:
            NameFull: Inada Y
      – PersonEntity:
          Name:
            NameFull: Yoshiji H
      – PersonEntity:
          Name:
            NameFull: Watanabe H
      – PersonEntity:
          Name:
            NameFull: Ishikawa H
      – PersonEntity:
          Name:
            NameFull: McPhee F
      – PersonEntity:
          Name:
            NameFull: Noviello S
      – PersonEntity:
          Name:
            NameFull: Kumada H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2018 Sep
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1435-5922
          Numbering:
            – Type: volume
              Value: 53
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Journal of gastroenterology
              Type: main
ResultId 1